Summary & Overview
HCPCS Level II P9071: Plasma (single donor), Pathogen Reduced, Frozen
HCPCS Level II code P9071 denotes a single-donor plasma unit that has undergone pathogen reduction and is supplied frozen. This product is clinically relevant for patients requiring plasma transfusion with enhanced infectious risk mitigation, and it carries implications for blood bank inventory, transfusion protocols, and payer coverage policies nationwide.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis addresses how this specific plasma product is coded for billing and how payers commonly approach coverage for specialized blood products.
Readers will find a concise explanation of the product and its service contexts, expected sites of service, and typical clinical use cases. The publication outlines what to expect in payer consideration and reimbursement coding practice, highlights common modifiers used in the field (listed separately), and notes where input data are not available. Policy and operational implications for hospitals, transfusion services, and billing teams are summarized to support administrative decision-making and coding accuracy.
Billing Code Overview
HCPCS Level II code P9071 represents plasma (single donor), pathogen reduced, frozen, each unit. This code describes a blood plasma product collected from a single donor that has undergone a pathogen reduction process and is supplied frozen in individual units.
Service type: Blood product transfusion/supply.
Typical site of service: Hospital inpatient and outpatient settings, transfusion centers, and other clinical sites where blood products are administered or stored prior to transfusion.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with end-stage liver disease and active gastrointestinal bleeding is admitted to the hospital. He is coagulopathic with an elevated INR and low fibrinogen; the transfusion medicine team orders P9071 (Plasma (single donor), pathogen reduced, frozen, each unit) to support hemostasis. The blood bank issues thawed, pathogen-reduced single-donor plasma units; units are transported to the operating room for an emergent endoscopic intervention and to the intensive care unit for ongoing resuscitation. Documentation includes indication, unit lot number, pathogen-reduction method, pre- and post-transfusion coagulation results, patient consent where required, and transfusion reaction monitoring notes. Billing occurs under the hospital outpatient or inpatient billing system depending on site of care, with applicable modifiers appended for circumstances such as professional component, reduced services, or bilateral procedures when relevant.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier - standard reporting | Use when no special circumstances apply to the plasma unit charge |
22 |